Robert Nelsen Beam Therapeutics Inc. (BEAM) insider trading activity

BEAM Quotes by TradingView

Robert Nelsen is Director of Beam Therapeutics Inc.. Currently has a direct ownership of 14,053 shares of BEAM, which is worth approximately $407,677. The most recent transaction as insider was on Mar 31, 2021, when has been sold 4,686 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.1K
0% 3M change
0% 12M change
Total Value Held $407,677

ROBERT NELSEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2021
BUY
Other acquisition or disposition
-
4,686 Added 25.01%
14,053 Common Stock
Mar 22 2021
BUY
Other acquisition or disposition
-
4,684 Added 33.34%
9,367 Common Stock
Mar 18 2021
BUY
Other acquisition or disposition
-
4,683 Added 50.0%
4,683 Common Stock

Also insider at

KRTX
Karuna Therapeutics, Inc. Healthcare
Director
SANA
Sana Biotechnology, Inc. Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
Director
DNLI
Denali Therapeutics Inc. Healthcare
Director
LYEL
Lyell Immunopharma, Inc. Healthcare
PRME
Prime Medicine, Inc.
Director
RN

Robert Nelsen

Director
Chicago, IL

Track Institutional and Insider Activities on BEAM

Follow Beam Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

News

Receive news related to Beam Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BEAM